Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 933 of 1,261
  1. US 8119631

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  2. US 8119649

    Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  3. US 8119769

    Complement depletion using recombinant human C-3 derivatives

    PLS-Design GmbH · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  4. US 8119796

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  5. US 8119618

    Compositions and methods for the treatment of inflammatory diseases

    The Board of Regents of the University of Oklahoma · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  6. US 8119827

    Compounds for treatment of cell proliferative diseases

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  7. US 8119642

    Structurally rigid dopamine D3 receptor selective ligands and process for making them

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  8. US 8119634

    Dual-acting pyrazole antihypertensive agents

    Theravance, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  9. US 8119655

    Kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  10. US 8119656

    Inhibitors of the influenza virus non-structural 1 protein

    The Board of Regents of the University of Texas System · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  11. US 8119660

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  12. US 8119809

    AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  13. US 8119779

    Phosphoramidate derivatives

    University College Cardiff Consultants Limited · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  14. US 8119772

    MART-1 T cell receptors

    The Regents of the University of California · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  15. US 8119608

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  16. US 8119398

    Adipose-derived stem cells for tissue regeneration and wound healing

    PrimeGen Biotech LLC · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  17. US 8119590

    Prevention and treatment of restenosis by local administration of drug

    Esperion Therapeutics, Inc. · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted
  18. US 8114852

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  19. US 8114981

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  20. US 8114900

    Amorphous carvedilol dihydrogen phosphate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  21. US 8114835

    Self-assembling peptide amphiphiles for tissue engineering

    Northwestern University · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  22. US 8114851

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  23. US 8114843

    Photoreactive regulator of protein function and methods of use thereof

    The Regents of the University of California · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted
  24. US 8114834

    Self-assembling peptide amphiphiles

    Northwestern University · Granted Feb 14, 2012 · Expires Feb 9, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.